RxDoctor Payments Data

Desiree Chizmadia

Nurse Practitioner · Cleveland, OHNPI 1801309695

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Novartis at 34.9% of the total. 2025 is the largest year on record at $6,742, 4.0 times the $1,683 reported in 2021. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,773in general payments, 2019–2025

Across 174 payments — averaging $84.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$5K
  • Sanofi$2K
  • EMD Serono, Inc.$1K
  • TG Therapeutics, Inc.$1K
  • Genentech USA, Inc.$1K
  • Biogen$978
  • plus $2K from 10 others

What the payments were for

  • Consulting fees$7,32150%
  • Speaking & faculty fees$6504%
  • Travel & lodging$9927%
  • Food & beverage$5,57738%
  • Education$2342%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,773 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$14,142
Medicare patients
111
Services billed
270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab32$348,509
Avonex Pen (4 Pack)Interferon Beta-1a13$152,486
Dalfampridine ErDalfampridine72$30,765
NuedextaDextromethorphan Hbr/Quinidine16$17,979
Baclofen473$10,305
Gabapentin413$8,516
Modafinil55$4,796
Duloxetine Hcl143$3,484
Trospium Chloride25$2,740
Pregabalin105$2,514
Tizanidine Hcl150$1,833
Oxcarbazepine35$1,516
AmantadineAmantadine Hcl55$1,148
Ropinirole Hcl50$941
Escitalopram Oxalate45$629

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →